The week of 2026-03-16, 20 holders filed a new Schedule 13D and 46 a new Schedule 13G reporting 5% or more of a company, and 1 13D filing stated in Item 4 an intent to influence the company. Open a company for every holder and the purpose each 13D states, quoted.
New Schedule 13D
| Filed | Company | Holder | Percent | Filing |
|---|---|---|---|---|
| 2026-03-19 | 2023 ETF Series Trust | Harrison Street Private Wealth LLC | 89.9% | SCHEDULE 13D |
| 2026-03-20 | K-Tech Solutions Co Ltd | Kwok Yiu Wah | 72.29% | SCHEDULE 13D |
| 2026-03-19 | Laird Superfood, Inc. | Nexus Capital Management LP | 56.7% | SCHEDULE 13D |
| 2026-03-18 | Primech Holdings Ltd | Ho Kin Wai | 46.88% | SCHEDULE 13D |
| 2026-03-20 | Intelligent Living Application Group Inc. | Bong Lau | 43.8% | SCHEDULE 13D |
| 2026-03-18 | Infinity Natural Resources, Inc. | INR (II) Investments, LLC | 41.44% | SCHEDULE 13D |
| 2026-03-16 | Happy City Holdings Ltd. | Suk Yee, Kwan | 40.3% | SCHEDULE 13D |
| 2026-03-17 | GDEV Inc. | Andrey Fadeev | 37% | SCHEDULE 13D |
| 2026-03-17 | AIOS Tech Inc. | Yanto | 32.6% | SCHEDULE 13D |
| 2026-03-20 | Eightco Holdings Inc. | Bitmine Immersion Technologies, Inc. | 31.94% | SCHEDULE 13D |
| 2026-03-18 | SUMA Acquisition Corporation | Naseem Saloojee | 26.02% | SCHEDULE 13D |
| 2026-03-16 | Unifirst Corp | Cintas Corp | 18.7% | SCHEDULE 13D |
| 2026-03-18 | NuCana plc | Hugh S. Griffith | 12% | SCHEDULE 13D |
| 2026-03-18 | Cango Inc. | Chiu, Chang-Wei | 11.99% | SCHEDULE 13D |
| 2026-03-20 | Horizon Quantum Holdings Ltd. | Harry L. You | 11.8% | SCHEDULE 13D |
| 2026-03-16 | Golub Capital Private Income Fund I | David B. Golub | 6.7% | SCHEDULE 13D |
| 2026-03-17 | Fortune Brands Innovations, Inc. | Pictet Asset Management Sa | 6.4% | SCHEDULE 13D |
| 2026-03-20 | Medifast Inc | Steamboat Capital Partners, LLC intent stated | 6% | SCHEDULE 13D |
| 2026-03-20 | Phunware, Inc. | Goldenwise Capital Group Ltd | 5.5% | SCHEDULE 13D |
| 2026-03-19 | Truworths International Ltd | Standard Bank Of South Africa Ltd | 5.1% | SCHEDULE 13D |
New Schedule 13G
| Filed | Company | Holder | Percent | Filing |
|---|---|---|---|---|
| 2026-03-18 | Pono Capital Four, Inc. | Mehana Ventures LLC | 28.5% | SCHEDULE 13G |
| 2026-03-16 | Maris Tech Ltd. | L.I.A. Pure Capital Ltd. | 10% | SCHEDULE 13G |
| 2026-03-18 | Zeta Network Group | L1 Capital Global Opportunities Master Fund, Ltd. | 9.99% | SCHEDULE 13G |
| 2026-03-18 | Promis Neurosciences Inc. | Wellington Biomedical Innovation Master Investors (Cayman) II, L.P. | 9.99% | SCHEDULE 13G |
| 2026-03-20 | Innovation Beverage Group Ltd | Lind Global Fund III LP | 9.99% | SCHEDULE 13G |
| 2026-03-16 | AN2 Therapeutics, Inc. | Commodore Capital LP | 9.9% | SCHEDULE 13G |
| 2026-03-17 | Korro Bio, Inc. | Venrock Healthcare Capital Partners III, L.P. | 9.9% | SCHEDULE 13G |
| 2026-03-20 | Equillium Inc. | RA Capital Management, L.P. | 9.9% | SCHEDULE 13G |
| 2026-03-16 | Charging Robotics Inc. | L.I.A. Pure Capital Ltd. | 9.8% | SCHEDULE 13G |
| 2026-03-18 | Knorex Ltd. | Vd Capital Pty Ltd | 9.8% | SCHEDULE 13G |
| 2026-03-17 | DevvStream Corp. | Helena Global Investment Opportunities 1 Ltd. | 9.59% | SCHEDULE 13G |
| 2026-03-18 | Netskope, Inc. | Canada Pension Plan Investment Board | 9.5% | SCHEDULE 13G |
| 2026-03-17 | Netskope, Inc. | Base Partners Consultoria de Investimentos E Negocios Ltda. | 9.4% | SCHEDULE 13G |
| 2026-03-19 | Tilly'S, Inc. | Leonard Braden Michael | 9.4% | SCHEDULE 13G |
| 2026-03-20 | NeoVolta, Inc. | Infinite Grid Capital, LP | 9.4% | SCHEDULE 13G |
| 2026-03-16 | Charging Robotics Inc. | Capitalink Ltd. | 9% | SCHEDULE 13G |
| 2026-03-17 | ETF Opportunities Trust | Andrew Hill Investment Advisors, Inc. | 8.94% | SCHEDULE 13G |
| 2026-03-16 | BRC Group Holdings, Inc. | Daniel Asher | 8.78% | SCHEDULE 13G |
| 2026-03-19 | Metals Acquisition Corp. II | Millennium Management LLC | 8.4% | SCHEDULE 13G |
| 2026-03-20 | Canada Goose Holdings Inc. | Fortune Enrichment Holdings Limited | 8.37% | SCHEDULE 13G |
| 2026-03-20 | Weave Communications, Inc. | Newtyn Management, LLC | 8% | SCHEDULE 13G |
| 2026-03-18 | Femasys Inc | PharmaCyte Biotech, Inc. | 7.87% | SCHEDULE 13G |
| 2026-03-16 | Vertical Data Inc. | Tiger Trout Capital Puerto Rico LLC | 7% | SCHEDULE 13G |
| 2026-03-17 | Aclaris Therapeutics, Inc. | Deep Track Capital, LP | 7% | SCHEDULE 13G |
| 2026-03-17 | Neuronetics, Inc. | Parian Ultreia LP | 7% | SCHEDULE 13G |
| 2026-03-16 | Edesa Biotech, Inc. | Perceptive Advisors LLC | 6.7% | SCHEDULE 13G |
| 2026-03-17 | Venu Holding Corporation | Kenneth Griffin | 6.4% | SCHEDULE 13G |
| 2026-03-20 | Canadian Solar Inc | D. E. Shaw & Co., L.P. | 6.4% | SCHEDULE 13G |
| 2026-03-17 | BankUnited, Inc. | Millennium Management LLC | 6% | SCHEDULE 13G |
| 2026-03-19 | Ww International, Inc. | Millennium Management LLC | 5.9% | SCHEDULE 13G |
| 2026-03-19 | ChronoScale Corp | Kosow Keith | 5.9% | SCHEDULE 13G |
| 2026-03-20 | TPG Inc. | Darlington Partners Capital Management, LP | 5.9% | SCHEDULE 13G |
| 2026-03-16 | Yext, Inc. | Millennium Management LLC | 5.8% | SCHEDULE 13G |
| 2026-03-20 | Grid Metals Corp | Brandon S Osborne | 5.53% | SCHEDULE 13G |
| 2026-03-17 | Gloo Holdings, Inc. | Stephen & Pamela Thorne 2020 Nevada Irrevocable Trust Dated December 18, 2020 | 5.4% | SCHEDULE 13G |
| 2026-03-19 | Day One Biopharmaceuticals, Inc. | Glazer Capital, LLC | 5.4% | SCHEDULE 13G |
| 2026-03-19 | Relay Therapeutics, Inc. | Perceptive Advisors LLC | 5.3% | SCHEDULE 13G |
| 2026-03-20 | Immix Biopharma, Inc. | Millennium Management LLC | 5.3% | SCHEDULE 13G |
| 2026-03-16 | Charging Robotics Inc. | Nissim Daniel | 5.2% | SCHEDULE 13G |
| 2026-03-18 | Adagene Inc. | Chernett Jorey | 5.1% | SCHEDULE 13G |
| 2026-03-18 | Atlas Energy Solutions Inc. | Encompass Capital Advisors LLC | 5.1% | SCHEDULE 13G |
| 2026-03-20 | Olema Pharmaceuticals Inc | Raymond Debbane | 5.1% | SCHEDULE 13G |
| 2026-03-20 | Delcath Sys Inc | Daniel Kaufman | 5.08% | SCHEDULE 13G |
| 2026-03-16 | Customers Bancorp, Inc. | Bay Pond Investors (Bermuda) L.P. | 5% | SCHEDULE 13G |
| 2026-03-18 | Dentsply Sirona Inc. | Southpoint Master Fund, LP | 5% | SCHEDULE 13G |
| 2026-03-18 | Oportun Financial Corp | Integrated Core Strategies (US) LLC | 5% | SCHEDULE 13G |
Stated intent
| Filed | Company | Holder | Percent | Filing |
|---|---|---|---|---|
| 2026-03-20 | Medifast Inc | Steamboat Capital Partners, LLC intent stated | 6% | SCHEDULE 13D |
Tools for this story
Each opens in a new tab. With no account yet, you sign up free and land on the result.
Where this comes from
Anyone who comes to own more than 5% of a class of a listed company's voting shares has to tell the SEC. A holder who may seek to change or influence the company files Schedule 13D, and has to say in Item 4, "Purpose of Transaction", what it intends to do. A holder with no such intent, such as many index and passive funds, may file the shorter Schedule 13G. Both are amended when the stake changes, including when it falls below 5%.
Every row here is one of those filings, linked to the filing itself. Percentages and share counts are exactly as the holder filed them, for the holder the filing names; an amendment showing a lower figure is shown as filed. Item 4 text is quoted word for word. Where a 13D's Item 4 contains a sentence stating a definite intent to influence the company, that sentence is marked and quoted; the page does not describe the holder or its motives beyond the words it filed. Nothing here is investment advice.